Oxadiazoles in Medicinal Chemistry

被引:563
作者
Bostrom, Jonas [1 ]
Hogner, Anders [1 ]
Llinas, Antonio [1 ]
Wellner, Eric [1 ]
Plowright, Alleyn T. [1 ]
机构
[1] AstraZeneca R&D, S-43183 Molndal, Sweden
关键词
DRUG-LIKE PROPERTIES; RECEPTOR ANTAGONISTS; CARBOXYLIC-ACIDS; DISCOVERY; 1,3,4-OXADIAZOLES; INHIBITORS; LIPOPHILICITY; PHARMACOLOGY; REPLACEMENTS; SELECTIVITY;
D O I
10.1021/jm2013248
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms. Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities. The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection. In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner. Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers. The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments). To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.
引用
收藏
页码:1817 / 1830
页数:14
相关论文
共 57 条
[1]
The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[2]
[Anonymous], ACD LOGD PH7 4 V10 A
[3]
[Anonymous], OECHEM PYTH TOOL KIT
[4]
[Anonymous], JAG V7 8
[5]
Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036
[6]
Do structurally similar ligands bind in a similar fashion? [J].
Bostrom, Jonas ;
Hogner, Anders ;
Schmitt, Stefan .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) :6716-6725
[7]
Exploiting personalized information for reagent selection in drug design [J].
Bostrom, Jonas ;
Falk, Niklas ;
Tyrchan, Christian .
DRUG DISCOVERY TODAY, 2011, 16 (5-6) :181-187
[8]
Antikinetoplastid activity of 3-aryl-5-thiocyanatomethyl-1,2,4-oxadiazoles [J].
Cottrell, DM ;
Capers, J ;
Salem, MM ;
DeLuca-Fradley, K ;
Croft, SL ;
Werbovetz, KA .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (11) :2815-2824
[9]
Profiling drug-like properties in discovery research [J].
Di, L ;
Kerns, EH .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (03) :402-408
[10]
Frisch M. J., 2004, GAUSSIAN 09